DE3161898D1 - 4,5-unsaturated prostanoic acid derivatives - Google Patents
4,5-unsaturated prostanoic acid derivativesInfo
- Publication number
- DE3161898D1 DE3161898D1 DE8181108759T DE3161898T DE3161898D1 DE 3161898 D1 DE3161898 D1 DE 3161898D1 DE 8181108759 T DE8181108759 T DE 8181108759T DE 3161898 T DE3161898 T DE 3161898T DE 3161898 D1 DE3161898 D1 DE 3161898D1
- Authority
- DE
- Germany
- Prior art keywords
- unsaturated
- acid derivatives
- prostanoic acid
- prostanoic
- pharmacological properties
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WGJJROVFWIXTPA-OALUTQOASA-N prostanoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC(O)=O WGJJROVFWIXTPA-OALUTQOASA-N 0.000 title 1
- 230000001262 anti-secretory effect Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/80—Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings
- C07C59/82—Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings the keto group being part of a ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/16—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/200,356 US4322543A (en) | 1979-11-28 | 1980-10-24 | 4,5-Unsaturated prostanoic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3161898D1 true DE3161898D1 (de) | 1984-02-16 |
Family
ID=22741378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8181108759T Expired DE3161898D1 (de) | 1980-10-24 | 1981-10-23 | 4,5-unsaturated prostanoic acid derivatives |
Country Status (14)
Country | Link |
---|---|
US (1) | US4322543A (de) |
EP (1) | EP0050849B1 (de) |
JP (1) | JPS57102861A (de) |
AT (1) | ATE5816T1 (de) |
AU (1) | AU546626B2 (de) |
CA (1) | CA1208633A (de) |
DE (1) | DE3161898D1 (de) |
DK (1) | DK469981A (de) |
ES (1) | ES506507A0 (de) |
FI (1) | FI813319L (de) |
IL (1) | IL64126A0 (de) |
NO (1) | NO813579L (de) |
PT (1) | PT73874B (de) |
ZA (1) | ZA817252B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4785124A (en) * | 1987-06-08 | 1988-11-15 | G. D. Searle & Co. | Process for preparing higher order cuprate complexes |
US5011958A (en) * | 1987-06-08 | 1991-04-30 | G. D. Searle & Co. | Process for preparing higher order cuprate complexes |
US4777275A (en) * | 1987-06-09 | 1988-10-11 | G. D. Searle & Co. | Process of preparing higher order cuprate complexes |
US5191109A (en) * | 1990-02-02 | 1993-03-02 | Sumitomo Chemical Company, Limited | Process for preparing optically active cyclopentenones |
US5218139A (en) * | 1990-12-27 | 1993-06-08 | G. D. Searle & Co. | Method for inhibiting IgE production |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3965143A (en) * | 1974-03-26 | 1976-06-22 | G. D. Searle & Co. | 16-Oxygenated prostanoic acid derivatives |
US4028419A (en) * | 1976-01-08 | 1977-06-07 | The Upjoin Company | 2-Decarboxy-2-hydroxymethyl-cis-4,5-didehydro-PGE, compounds |
US4254285A (en) * | 1977-12-08 | 1981-03-03 | American Cyanamid Company | 1-Hydroxymethyl-1-1-oxo prostane derivatives of the E and F series |
US4311707A (en) * | 1979-02-12 | 1982-01-19 | American Cyanamid Company | Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions |
-
1980
- 1980-10-24 US US06/200,356 patent/US4322543A/en not_active Expired - Lifetime
-
1981
- 1981-10-20 ZA ZA817252A patent/ZA817252B/xx unknown
- 1981-10-22 JP JP56169419A patent/JPS57102861A/ja active Granted
- 1981-10-23 AT AT81108759T patent/ATE5816T1/de not_active IP Right Cessation
- 1981-10-23 DK DK469981A patent/DK469981A/da not_active Application Discontinuation
- 1981-10-23 ES ES506507A patent/ES506507A0/es active Granted
- 1981-10-23 FI FI813319A patent/FI813319L/fi not_active Application Discontinuation
- 1981-10-23 CA CA000388601A patent/CA1208633A/en not_active Expired
- 1981-10-23 EP EP81108759A patent/EP0050849B1/de not_active Expired
- 1981-10-23 PT PT73874A patent/PT73874B/pt unknown
- 1981-10-23 AU AU76768/81A patent/AU546626B2/en not_active Ceased
- 1981-10-23 DE DE8181108759T patent/DE3161898D1/de not_active Expired
- 1981-10-23 NO NO813579A patent/NO813579L/no unknown
- 1981-10-27 IL IL64126A patent/IL64126A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA817252B (en) | 1983-01-26 |
ES8301870A1 (es) | 1983-01-01 |
EP0050849B1 (de) | 1984-01-11 |
ATE5816T1 (de) | 1984-01-15 |
ES506507A0 (es) | 1983-01-01 |
EP0050849A1 (de) | 1982-05-05 |
JPS57102861A (en) | 1982-06-26 |
IL64126A0 (en) | 1982-01-31 |
AU7676881A (en) | 1982-04-29 |
PT73874A (en) | 1981-11-01 |
US4322543A (en) | 1982-03-30 |
PT73874B (en) | 1985-11-12 |
NO813579L (no) | 1982-04-26 |
AU546626B2 (en) | 1985-09-12 |
JPH039093B2 (de) | 1991-02-07 |
DK469981A (da) | 1982-04-25 |
CA1208633A (en) | 1986-07-29 |
FI813319L (fi) | 1982-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT7824074A0 (it) | Apparecchiatura di controllo di errori di velocita'. | |
IT8119459A0 (it) | 25-idrossi-26,26,26,27,27,27-esaflu orocolecalciferolo. | |
SE8008300L (sv) | 4,5-omettade prostansyraderivat | |
ATE5816T1 (de) | 4,5-ungesaettigte prostansaeurederivate. | |
DK267781A (da) | 2,3-bis-hydroxybenzylderivater | |
ATE22293T1 (de) | Substituierte tetrahydropyridazino(1,6a)benzimidazole. | |
SE7902404L (sv) | 2,3-dihydro-4h-1-bensopyran-4-on-o-karbamoyloximer | |
IE820686L (en) | Prostanoic acid derivatives. | |
ES507706A0 (es) | Procedimiento para la fabricacion de derivados de 5,6,7,7atetrahidro-4h-tieno(3,2-c)-piridin-2-ona . | |
NL186632C (nl) | Werkwijze ter bereiding van 2,2'-bis-(4-gesubstitueerd fenol)sulfiden, alsmede een 2,2'-bis(4-gesubstitueerd fenol)sulfide. | |
ES471088A1 (es) | Un procedimiento para la preparacion de derivados de 2-oxa- zolidinona | |
ES459898A1 (es) | Un procedimiento para la preparacion de acido 6,11-dihidro- dibenzo (b. e.) tiepin-11-on-3-acetico. | |
ATE24476T1 (de) | 1,3-dihalopropan-2-ole. | |
IT1189011B (it) | 1,4;3,6-dinanidro-2,5-diazido-2,5-dideossi-esitoli | |
AU496087B2 (en) | Prostaglandin-type, 1, 15 lactones | |
AU496088B2 (en) | Prostaglandin-type 1, 9-lactones | |
AU496552B2 (en) | Prostaglandin-type 1, 11-lactones | |
SU606226A1 (ru) | Автоматический номеронабиратель | |
SU553245A1 (ru) | Способ получени 8,8"-диокси-5,5"дихинолилдисульфида | |
AU1428976A (en) | Prostaglandin-type 1, 9-lactones | |
ATE24517T1 (de) | 3,5,12-trihydroxy-6,11-dioxonaphthacene. | |
IT8020243A0 (it) | Chinazoline 2,4,6,7-tetrasostituite. | |
FI871886A0 (fi) | 2-substituerade 1,3-dihalogenpropan-2-oler. | |
FI821314A0 (fi) | 5,6-0-isoalkydien-askorbinsyra-derivater | |
NO861695L (no) | Nye 10-(1,2-propadienyl)steroider. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |